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Abstract
One of the keys to high quality paediatric asthma management is the provision of age appropriate information
regarding the disease and its management. In order to determine whether the generation of a minimum dataset of
information which can be translated into a wide range of languages might be used to assist children and their
parents around the world, we undertook a survey of national Member Societies of the World Allergy Organization
(WAO) to determine what educational material on asthma for children and their families already exists.
A questionnaire was developed using Survey Monkey and distributed in 2014 to 263 representatives of the WAO
member Societies from 95 countries.
Thirty-three replies were received from thirty-one countries. The survey highlighted a considerable disparity in
availability of material among the responding countries, with some countries reporting that information was freely
available in hard copy and online and others reporting a lack of suitable material locally.
The results highlight the need to develop a core set of simple, clear and consistent age appropriate information
that can be easily translated and delivered in a cultural and educationally effective format.
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Background
Asthma remains the commonest chronic disease of
childhood and is associated with high levels of morbid-
ity [1–6]. The World Health Organisation (WHO) has
estimated that there are 300 million individuals with
asthma worldwide with a projected growth of a further
100 million over the next decade [4]. A high proportion
of these asthmatic subjects are children. Although the
prevalence varies from region to region and country to
country [1–5], the majority of individuals with asthma
live in developing countries. The severity of the condi-
tion varies from occasional relatively mild symptoms to
frequent troublesome symptoms that have a dramatic
impact on quality of life and are associated with life
threatening attacks. Indeed, WHO has estimated that
asthma is responsible for 250,000 deaths per annum
worldwide [4]. Currently, there is no cure for asthma,
but there is good evidence that drugs such as inhaled
corticosteroids [ICS], which have been available for
more than 40 years, can transform the lives of most
patients with symptoms of sufficient frequency and/or
severity to require regular ‘preventer’ therapy. However,
in order to reap the benefit of these drugs in terms of
improved quality of life, protection against day to day
bother, night time wakening, missed school or work
due to exacerbation and indeed reduced mortality, the
patient is required to use the ICS aerosol delivery sys-
tem effectively every day [5, 7] - something that is
rarely achieved. Consequently unnecessarily high levels
of morbidity and mortality continue to be reported
from countries around the globe both in developing
[4–6, 8] and developed countries [9–11].
Although the basics of good asthma care generally in-
volve doing the simple things right; that is, ensuring the
diagnosis is correct, identifying any co-morbidities that
may be exacerbating or mimicking asthmatic symptoms
and, in those with sufficient symptoms to warrant a
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preventer therapy, ensuring the medication is taken
regularly and effectively. Getting this right has been
shown to yield huge benefits for patients and for health-
care systems with reduced hospitalisations, unscheduled
health care contacts and deaths. However, there are
many impediments to translating the potential of
current interventions into real life as outlined by many
authors and organisations, and most are relevant to a
greater or lesser degree in all health care settings. These
included lack of availability of medication, cost of medi-
cation, lack of awareness of the nature of the disease in
the community, lack of an appropriate informed and
knowledgeable cohort of health care professionals, lack
of access to health care professionals and lack of know-
ledge linked to self-management among patients and
their families.
A number of countries have developed National
Asthma Plans [12, 13] to address many of these issues
and report significant success in terms of improved out-
comes for patients and reduced health care costs for the
providers. One aspect of all such plans is the provision
of cultural and age appropriate specific information for
the patient and their family linked to a treatment plan
and self-management. This echoes current beliefs about
the optimal approaches to the management of chronic
diseases in general as well as current recommendations in
national and international guidelines for the management
of asthma (http://www.ginasthma.org/), (http://www.sign.
ac.uk/pdf/SIGN141.pdf). In some European countries
such as Germany, pediatric asthma schools have become
an essential part of outpatient care and are reimbursed by
the National Health Insurances. In others, there are valu-
able resources available at a national and/or local level
which can be used by health care professionals in develop-
ing a partnership with the patient, or accessed by children
and families independently via the internet. However in
many countries, there are no such resources or if they
exist they are only available at certain centres.
Based on a perceived need, the World Allergy
Organization (WAO) Committee on Pediatric Asthma
proposed that consideration should be given to the devel-
opment of a WAO educational program for pediatric
asthma that could be tailored to the needs of different re-
gions and countries. The objectives of the WAO program
would be: (1) To improve the quality of life of asthmatic
children, provide maximum autonomy in spite of the
chronic disease, and optimize the available treatment op-
tions for children. (2) Ensure that no matter where
children diagnosed with asthma grow up, they and their
caregivers will receive the same degree of minimum edu-
cation. The aim of this study was to identify the types of
educational material available around the world and to de-
termine whether a core multi-lingual resource available to
health care professionals and patients would be valuable.
Methods
A questionnaire was developed using the Survey Monkey
application and distributed to 263 individuals from 95
WAO Member Societies around the world. The survey
sought information regarding the availability and quality
of educational material aimed at children and parents
available in that country and whether material was avail-
able online.
Results
Thirty-three replies were received from 31 countries, as
documented in Table 1. The distribution of responses in-
cluded 11 countries in Europe, 8 in South America, 3 in
the Indian sub-continent, 3 in the Middle East, 2 in Africa,
2 in the Far East and one each from North America and
Australasia.
The availability of patient educational material varied
from those reporting that printed information was
widely available in both hard copies and on the Internet
to others who report no specific educational material be-
ing available. Among the comments made, many re-
ported that when information was available in printed
form in a country its availability was limited due to poor
distribution and access. Others commented on the lack
of age appropriate material, lack of time to participate in
the educational process, the absence of material de-
signed to address cultural, and educational aspects of pa-
tient understanding of their disease. In a search of
available literature in the English language a number of
resources with translations were found.
Discussion
The results from this survey, while limited to only 31
countries, highlight the significant disparities regarding
the availability of educational material aimed at children
with asthma and their parents across the globe. As such,
it highlights the opportunity for creating a core educa-
tional resource that can then be developed for specific
languages taking into account local cultural issues. The
information referred to by the respondents to this survey
is almost all written with some illustration, a further
limitation for its use in many settings. With the expo-
nential increase in mobile phone use around the world
as well as the prevalence of the Internet, the focus of
any developments in this area should probably be in the
field of downloadable “apps” and online developments
which would potentially address issues of literacy and
cultural disconnect.
There is an extensive literature regarding the use of edu-
cation in influencing health care outcomes in those with
chronic diseases. It appears in many health care settings
that the provision of information alone is, in the majority
of cases, not sufficient to change health care beliefs and
behaviour. The key aspects of the “educational” message
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and the format in which it is presented that do make
a difference have not been clearly identified. Where
change has been effective the education has been part
of a greater package which includes improved know-
ledge among health care professionals delivering the
care, greater accessibility to health care professionals
with specific expertise, more frequent structured con-
tact between the health care system and patient, a
focus on a partnership approach to health care and
practical issues such as addressing the cost burden
for patients [14–19]. The greatest benefits for patients
appear to be gained where a national structured ap-
proach is adopted. Such National Asthma Plans are
unlikely to be rolled out in many countries due to
lack of resources, considerations that asthma is a low pri-
ority in the context of that country or in-built institutional
issues or self-interest. In the absence of a National Plan,
the provision of opportunistically providing education to
those presenting to emergency departments or admitted
to hospital have been shown to reduce subsequent presen-
tations and hospitalisations. Furthermore, while there are
questions about the effectiveness of information alone in
changing behaviour, the inability to readily access simple,
clear and accurate information in an appropriate format
places the majority of subjects with asthma at great
disadvantage.
Table 1 Summary of survey responses
Country Are there national bodies producing asthma
educational material and/are they of high
enough quality?
Accessible via web? Do you use this
material?
Is there evidence for
its effectiveness?
Argentina Yes/Yes Google, Medline, etc. Yes Yes insufficient
Australia Yes/Yes Nationalasthma.org.au Yes Yes unsure what
Austria Yes/Yes No Yes Yes for some issues
Bangladesh Yes/No Hard copy only Yes Yes
Belarus Yes/Yes Yes Yes Yes




[Eng & French] www.lung.ca
Yes No No No
Croatia Yes/Yes asjastipic90@gmail.com Yes Yes
Cuba Yes/Yes www.sld.cu/sitios/asma/ www.infomed.sld.cu Yes No
Denmark No -pharma prod material is available - -
Ecuador No From AAAAI and WAO - -
Egypt Yes/No www.espai-eg.org/espai.htm Yes No
Greece No - - -
Portugal Yes/Yes Hard copy only Yes Yes a little
India No Yes/Yes Is pharma prod material Yes -- --
Iran Yes/Yes Iranian Society of Asthma & Allergy (ISAA) Yes No
Japan Yes/Yes Yes Yes Yes
Kuwait Yes/No No Yes Yes
Latvia Yes/No yes Yes No
Lebanon No -Is pharma prod material - -
Panama Yes/No No No Yes
Sri Lanka Yes/No No No




Turkey Yes/No No Yes Yes




Venezuela Yes/No No - -
Zimbabwe No - - -
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Conclusion
The results of this international survey highlight the need
to develop a core set of simple, clear and consistent age
appropriate information that can be easily translated and
delivered in a cultural and educationally appropriate for-
mat. The use of mobile phones and the internet allowing
the presentation of both visual and auditory information,
together with resources of pictorial action plans, has the
potential to greatly enhance the reach of the information
to population currently largely excluded. Increased
provision of these educational resources can support the
goals of improved paediatric asthma management.
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